innerbuddies gut microbiome testing

Gut Microbiome and Prediabetes: How Impaired Fasting Glucose Is Influenced

Impaired fasting glucose is often an early warning sign that your body is beginning to struggle with blood-sugar regulation. While genetics, sleep, stress, and activity matter, an increasingly important influence is the gut microbiome—the trillions of microbes that help shape digestion, inflammation, and how your body processes carbohydrates.

In people with impaired fasting glucose, studies suggest the gut ecosystem may shift in ways that affect insulin sensitivity and glucose control. Certain microbial patterns can influence how quickly nutrients are absorbed, how strongly the gut barrier holds, and how much inflammation is produced from microbial metabolites. Less diversity and an imbalance in beneficial bacteria may also alter the production of key compounds—such as short-chain fatty acids—that support healthier metabolic function.

The good news: improving your gut microbiome can be a practical, evidence-based way to support healthier fasting glucose and lower prediabetes risk. By focusing on gut-friendly fiber, fermented foods (if tolerated), and microbiome-supportive lifestyle habits—along with targeted medical guidance when needed—you can help create an internal environment where glucose regulation is easier to maintain.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Impaired fasting glucose

Impaired fasting glucose (IFG) is a condition where fasting blood sugar is higher than normal but not high enough to be diabetes. It’s an early warning sign of prediabetes and reflects emerging insulin resistance. The overview highlights that, in addition to diet, weight, sleep, and activity, the gut microbiome can influence overnight glucose regulation and insulin sensitivity.

The gut microbiome impacts IFG through mechanisms such as fermentation of dietary fiber into short-chain fatty acids (SCFAs) like butyrate and propionate, which support insulin signaling. Dysbiosis can promote low-grade inflammation and a leaky gut, worsening insulin resistance, and microbiome-driven changes in bile acid metabolism and other metabolites can alter energy balance and glucose handling.

Practical guidance focuses on a high‑fiber, minimally processed diet and, for some people, fermented foods, along with regular exercise, healthy waist size, good sleep, and reduced ultra-processed foods. Because responses vary, a personalized approach guided by a clinician is best, including monitoring fasting glucose. Tools like microbiome testing and services such as InnerBuddies can help tailor diet changes and track what works over time.

  • Boost or preserve butyrate- and propionate-producers like Faecalibacterium prausnitzii, Roseburia spp., Eubacterium rectale, and Ruminococcus bromii to support overnight insulin signaling and lower fasting glucose (a core mechanism in IFG).
  • Support gut barrier and anti-inflammatory microbes such as Akkermansia muciniphila and Bifidobacterium spp.; higher levels are linked with better insulin sensitivity and lower IFG risk.
  • Avoid or reduce overgrowth of pro-inflammatory and dysbiotic taxa—Escherichia coli, Enterobacteriaceae, Desulfovibrio, and Ruminococcus gnavus—to reduce systemic inflammation and insulin resistance associated with IFG.
  • Dysbiosis-driven changes in bile acid metabolism by gut microbes can alter FXR/TGR5 signaling; targeted taxa shifts that favor favorable bile acids may improve glucose homeostasis.
  • Dietary fiber fermentation is the key mechanism; increasing diverse, high-fiber foods (vegetables, legumes, whole grains) promotes SCFA production and improves fasting glucose.
  • Testing and personalization: Microbiome analysis can guide which fiber types to emphasize and whether fermented foods will help, enabling clinician-guided monitoring of fasting glucose for IFG management.
Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Prediabetes

Impaired fasting glucose (IFG) means your blood sugar level is higher than normal after an overnight fast, but not high enough to be classified as type 2 diabetes. It’s often considered a key early warning sign of prediabetes and reflects a growing mismatch between how much glucose your body needs to manage and how effectively the liver and muscles respond to insulin. While lifestyle factors such as diet quality, body weight, sleep, and physical activity strongly influence IFG, emerging research shows that the gut microbiome can also play an important role in shaping insulin sensitivity and glucose regulation.

The gut microbiome influences fasting glucose through several connected pathways: microbial fermentation of dietary fiber produces short-chain fatty acids (SCFAs) like butyrate and propionate, which can support metabolic health and improve insulin signaling. Conversely, dysbiosis—an imbalance in gut microbes—may contribute to low-grade inflammation and altered gut barrier function (often referred to as “leaky gut”), which can worsen insulin resistance. Additionally, microbiome-driven changes in bile acid metabolism and the production of metabolites that affect host energy balance (including those linked to glucose and lipid handling) may help explain why some people develop IFG even when traditional risk factors are modest.

Diet is typically the most actionable lever for supporting a healthier microbiome in the context of IFG. Emphasizing high-fiber, minimally processed foods (vegetables, legumes, whole grains, nuts, and seeds), and including fermented foods for some individuals, can encourage beneficial microbes and SCFA production. Evidence-based habits—regular physical activity, maintaining a healthy waist circumference, improving sleep quality, and reducing ultra-processed foods and added sugars—also tend to foster a more glucose-supportive microbial environment. Because microbiome composition and response to diet vary by person, the most effective approach is often personalized: pairing practical dietary changes with consistent monitoring of fasting glucose and related markers as guided by a clinician.

  • Higher-than-normal fasting blood glucose (often detected on lab testing before noticeable symptoms)
  • Increased thirst or dry mouth
  • Frequent urination
  • Unintended weight gain or difficulty losing weight
  • Fatigue or low energy
  • Blurred vision
  • Increased hunger or cravings (especially for carbohydrates)
  • Frequent skin infections or slow wound healing
Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Impaired fasting glucose

Impaired fasting glucose (IFG) is most relevant for people whose overnight (fasting) blood tests show glucose is higher than normal but not yet in the diabetes range—often discovered during routine screening even if you don’t feel “sick.” It’s also especially relevant if you’re noticing early metabolic shifts such as more frequent hunger or carbohydrate cravings, low energy, or difficulty maintaining weight despite usual habits. In these situations, IFG can signal early insulin resistance, where diet, body composition, sleep, stress, and gut microbial balance may all be contributing factors.

IFG may be particularly important to address when symptoms overlap with higher blood sugar patterns, such as increased thirst or dry mouth, frequent urination, blurred vision, fatigue, and slow wound healing or frequent skin infections. These clues can indicate that glucose regulation is already strained, and that further progression toward type 2 diabetes is possible without intervention. For many people, improving gut health—by supporting beneficial microbes that produce helpful short-chain fatty acids (SCFAs) like butyrate and propionate—can be one pathway that complements standard lifestyle changes.

It’s also relevant for anyone looking for personalized, longer-term strategies to support insulin sensitivity beyond “generic” advice—especially if you’ve tried to improve diet but struggled with consistency, have high intake of ultra-processed foods, added sugars, or low fiber, or suspect that GI symptoms or irregular eating patterns may be affecting you. Because gut microbiome composition varies widely, people with IFG may benefit from targeted nutrition habits (more legumes, vegetables, whole grains, nuts/seeds, and possibly fermented foods if tolerated) along with ongoing monitoring of fasting glucose and related markers under clinician guidance.

Impaired fasting glucose (IFG) is common and is widely viewed as an early stage in the progression toward prediabetes and type 2 diabetes. In large population studies, IFG is typically estimated to affect roughly 1 in 4 adults (about 25%) in some countries/age groups, though rates vary substantially by ethnicity, age, and how fasting glucose thresholds are defined.

IFG prevalence tends to rise with age and is strongly linked with overall cardiometabolic risk. Many people with IFG are asymptomatic, meaning the condition is often discovered only through routine lab testing—consistent with symptoms such as elevated fasting glucose, which may be accompanied by subtle signs like increased thirst or dry mouth, more frequent urination, fatigue, or blurred vision, but these are not always noticeable.

Because IFG reflects early dysregulation of insulin response (rather than established diabetes), it overlaps with other metabolic patterns that are also influenced by lifestyle and gut health. For example, higher rates are commonly seen in adults with excess visceral adiposity, low dietary fiber intake, sedentary behavior, sleep disruption, and higher consumption of ultra-processed foods—factors that can shape the gut microbiome and contribute to insulin sensitivity changes. As a result, the burden of IFG in real-world settings is substantial, with population estimates frequently landing around the mid–20th percentile (often ~20–30% of adults), making it a frequent clinical “warning” finding rather than a rare condition.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Gut Microbiome & Prediabetes: How Impaired Fasting Glucose Is Influenced

Impaired fasting glucose (IFG) may be influenced by the gut microbiome through its effects on insulin sensitivity and glucose regulation, especially overnight when you’re fasting. Many beneficial gut bacteria ferment dietary fiber into short-chain fatty acids (SCFAs) such as butyrate and propionate, which can support healthier metabolic signaling and improve how the liver and muscles respond to insulin. When fiber intake is low or the microbial community is less diverse, SCFA production may drop, potentially contributing to higher fasting blood sugar.

Gut dysbiosis (microbial imbalance) can also promote low-grade inflammation and compromise the intestinal barrier, sometimes described as “leaky gut.” Inflammation-related changes and altered gut barrier function can affect insulin signaling and increase insulin resistance, helping explain why some people develop IFG even without major traditional risk factors. Additionally, the microbiome can influence bile acid metabolism and produce metabolites that affect host energy balance and pathways involved in glucose and lipid handling.

These microbiome-driven shifts may connect to the common IFG signs—such as fatigue, increased thirst/dry mouth, frequent urination, blurred vision, and carbohydrate cravings—because impaired glucose control can influence hydration status, energy availability, and hunger regulation. Diet is typically the most actionable way to support a glucose-supportive microbiome: prioritizing high-fiber, minimally processed foods (vegetables, legumes, whole grains, nuts, and seeds) and, for some individuals, including fermented foods can encourage beneficial microbes and SCFA production. Since responses vary person to person, combining targeted dietary changes with clinician-guided monitoring of fasting glucose and related markers can help tailor the approach.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Gut Microbiome and Impaired fasting glucose

  • SCFA production (butyrate/propionate) from fermenting dietary fiber improves insulin sensitivity by enhancing metabolic signaling in the liver and skeletal muscle—particularly important for glucose control during fasting
  • Gut dysbiosis can increase low-grade inflammation (via immune and microbial metabolite signaling), which worsens insulin receptor signaling and promotes insulin resistance
  • Intestinal barrier dysfunction (“leaky gut”) allows microbial components (e.g., LPS) to enter circulation, triggering inflammatory pathways that impair insulin action and elevate fasting glucose
  • Altered bile acid metabolism changes activation of host receptors (e.g., FXR/TGR5) that regulate glucose homeostasis and insulin sensitivity
  • Microbiome-driven changes in gut-derived metabolites (beyond SCFAs, such as secondary bile acids and other fermentation products) can shift pathways controlling hepatic glucose output and peripheral glucose uptake
  • Reduced microbial diversity and lower fiber intake can decrease beneficial taxa that support glucose regulation, weakening the microbiome’s ability to maintain normal fasting glycemic control
  • Changes in gut signaling hormones (incretins like GLP-1/GIP) and satiety pathways may indirectly affect glucose regulation and cravings, contributing to impaired fasting glucose patterns

Impaired fasting glucose (IFG) can be shaped by the gut microbiome, particularly during overnight fasting when the liver is responsible for maintaining blood sugar. A microbiome that can ferment adequate dietary fiber produces short-chain fatty acids (SCFAs) such as butyrate and propionate. These metabolites help improve insulin sensitivity by enhancing metabolic signaling in the liver and skeletal muscle—supporting how the body controls glucose output and peripheral uptake while you’re not eating.

When gut dysbiosis reduces microbial diversity or fiber fermentation, SCFA production can fall, and metabolic control may weaken. At the same time, dysbiosis may contribute to low-grade inflammation by altering immune signaling and microbial metabolite patterns. Chronic inflammatory signaling can impair insulin receptor activity and promote insulin resistance, which makes it harder to keep fasting glucose within a normal range.

Microbiome effects can also involve gut barrier and bile-acid pathways. In some people, intestinal barrier dysfunction (“leaky gut”) allows microbial components (e.g., LPS) to reach circulation more easily, triggering inflammation that further disrupts insulin action and elevates fasting glucose. In parallel, the microbiome modifies bile acid composition, influencing host receptors such as FXR and TGR5 that regulate glucose homeostasis and insulin sensitivity; additional fermentation-derived metabolites can shift liver and peripheral glucose-handling pathways. Together, these changes can connect microbial patterns to common IFG experiences like fatigue, thirst/urinary frequency, and carbohydrate cravings by affecting glucose availability, metabolic signaling, and gut-derived hormonal cues involved in appetite and glucose regulation.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Microbial patterns summary

People with impaired fasting glucose (IFG) often show a gut microbiome pattern with reduced microbial diversity and lower abundance of fiber-fermenting taxa. When the community is less able to break down dietary fiber, production of short-chain fatty acids (SCFAs)—especially butyrate and propionate—tends to be diminished. Because SCFAs support metabolic signaling pathways that improve how the liver regulates glucose output overnight and how skeletal muscle responds to insulin, a microbiome that generates fewer SCFAs can align with higher fasting blood sugar.

IFG is also commonly linked with dysbiosis that promotes low-grade inflammation and altered immune signaling. Shifts in the microbiome can weaken gut barrier integrity, sometimes described as increased intestinal permeability, allowing pro-inflammatory microbial components such as LPS to influence systemic inflammation. This inflammatory environment can interfere with insulin receptor activity and downstream insulin signaling, contributing to insulin resistance that manifests as impaired fasting glucose even when daytime post-meal control is relatively preserved.

Another frequently discussed microbial pattern involves altered bile acid metabolism and changes in gut-derived metabolite signaling. The microbiome can modify bile acid profiles, which then interact with host receptors like FXR and TGR5 that regulate glucose homeostasis and insulin sensitivity. In parallel, changes in fermentation-derived metabolites can influence hepatic and peripheral pathways involved in glucose and lipid handling, shaping overall metabolic regulation. Together, these bile-acid and metabolite shifts help explain how gut microbial differences may be associated with symptoms such as fatigue, thirst or frequent urination, blurred vision, and carbohydrate cravings through their effects on glucose availability, inflammatory tone, and gut-hormonal cues.


Low beneficial taxa

  • Faecalibacterium prausnitzii
  • Eubacterium rectale
  • Roseburia spp.
  • Ruminococcus bromii
  • Bifidobacterium spp.
  • Akkermansia muciniphila
  • Butyrivibrio spp.
  • Prevotella spp.


Elevated / overrepresented taxa

  • Escherichia coli
  • Enterobacteriaceae (family-level)
  • Desulfovibrio (sulfate-reducing bacteria)
  • Bacteroides (some species/strains)
  • Ruminococcus gnavus (and related inflammatory Ruminococcus taxa)


Functional pathways involved

  • Dietary fiber fermentation to short-chain fatty acids (SCFAs), including butyrate and propionate production
  • Glucose and carbohydrate metabolism pathways that influence intestinal gluconeogenesis and host glucose signaling
  • Regulation of gut barrier integrity and mucin/biofilm-related functions that affect intestinal permeability (e.g., tight junction support and mucus layer maintenance)
  • Microbial LPS and other pro-inflammatory component biosynthesis/processing that drives low-grade systemic inflammation
  • Bile acid metabolism and transformation (primary-to-secondary bile acids) that modulates FXR/TGR5 signaling for glucose homeostasis
  • Sulfate-reduction and hydrogen sulfide (H2S) generation pathways that can promote mucosal inflammation and impair insulin sensitivity
  • Branched-chain amino acid (BCAA) and amino-acid catabolism pathways that influence insulin signaling and metabolic inflammation
  • Microbial immune-modulating metabolite signaling (e.g., indole/tryptophan-derived metabolites) that shapes inflammatory tone and insulin responsiveness


Diversity note

In people with impaired fasting glucose (IFG), gut microbiome studies commonly report reduced overall microbial diversity along with fewer beneficial, fiber-fermenting microbes. This matters because a less diverse community is often less efficient at breaking down dietary fiber into short-chain fatty acids (SCFAs) such as butyrate and propionate. Since SCFAs help regulate metabolic signaling, they can influence how the liver controls overnight glucose output and how skeletal muscle responds to insulin—two key processes that drive fasting blood sugar.

Alongside lower diversity, IFG is frequently associated with gut dysbiosis that supports a more pro-inflammatory environment. When microbial imbalance shifts the composition and function of the intestinal ecosystem, it may impair gut barrier integrity, sometimes described as increased intestinal permeability. This can allow inflammatory microbial components to exert greater effects system-wide, where low-grade inflammation can interfere with insulin receptor signaling and promote insulin resistance—contributing specifically to elevated fasting glucose.

Finally, diversity changes often coincide with altered microbial metabolite production, including modifications to bile acid profiles. Gut bacteria transform primary bile acids into secondary forms that interact with host receptors involved in glucose homeostasis (such as FXR and TGR5), and differences in metabolite signaling can affect hepatic and peripheral pathways for glucose and lipid handling. Together, these diversity-linked shifts in SCFAs, inflammation-related signaling, and bile acid metabolism help explain why gut microbiome patterns may track with IFG and its common metabolic symptoms.


Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription

Why generic solutions fail

  • Issue with generic solutions

    Generic solutions often fail for impaired fasting glucose because IFG is tightly linked to overnight physiology—especially liver glucose production and early insulin signaling—while many “one-size-fits-all” gut approaches focus on daytime digestion or broad probiotic use without addressing the specific microbial functions that affect fasting glucose. If the microbiome lacks fiber-fermenting capacity (e.g., reduced butyrate/propionate-producing taxa), simply adding a random probiotic or making small diet changes may not restore the short-chain fatty acid output needed to improve insulin sensitivity and metabolic signaling during fasting.

    Another common reason generic strategies underperform is that not all dysbiosis is the same. Some people have patterns that more strongly drive low-grade inflammation and impaired gut barrier function, while others may have more pronounced bile-acid or metabolite signaling differences. If a plan doesn’t match the dominant driver—fiber-fermentation shortfall versus inflammatory barrier disruption versus altered bile acid signaling—participants can see minimal change in fasting glucose even if they notice digestive improvements.

    Finally, generic recommendations often ignore individual response variability and the time needed for microbiome remodeling. Fasting glucose is influenced by multiple interacting factors (dietary fiber type, baseline microbial diversity, medications such as metformin, sleep/circadian rhythm, stress, and baseline insulin sensitivity). Without clinician-guided monitoring and personalization, people may miss that they need a targeted shift in substrate (specific fermentable fibers), targeted timing (to influence overnight metabolic signaling), and an assessment of whether inflammation or bile acid pathways are the more relevant bottlenecks for their microbiome.

  • Common mistakes

    • Using generic probiotic recommendations without targeting the specific missing microbiome functions behind IFG (e.g., low fiber-fermenting taxa that reduce butyrate/propionate production).
    • Failing to address overnight physiology (liver glucose output and early insulin signaling) and instead focusing only on daytime digestion or post-meal responses.
    • Assuming all dysbiosis is the same—without determining whether the dominant driver is reduced SCFA generation, inflammatory gut-barrier disruption (e.g., LPS/inflammation), or altered bile-acid/metabolite signaling.
    • Making insufficient or nonspecific dietary fiber changes (wrong fiber type, too little fermentable substrate, or no progression), so SCFA output isn’t meaningfully restored.
    • Ignoring medication and metabolic confounders (especially metformin) that can change microbiome composition and fasting glucose independently of diet supplements.
    • Not using monitoring/personalization (e.g., lack of fasting glucose trends, symptom tracking, or biomarker-informed adjustments), leading to plans that don’t match the individual’s bottleneck or response.
    • Expecting rapid microbiome remodeling—starting and stopping interventions too quickly or not allowing enough time to see changes in fermentation metabolites and fasting glucose regulation.

What to do

  • General support strategies

    For impaired fasting glucose, a gut-focused approach often centers on improving insulin sensitivity and steadying overnight glucose regulation. Because many gut microbes rely on dietary fiber to produce short-chain fatty acids (SCFAs) like butyrate and propionate, supporting regular, fermentable fiber intake can help promote a healthier metabolic signaling environment. Aim for a steady pattern of high-fiber foods—such as vegetables, legumes, whole grains, nuts, and seeds—to nourish microbial diversity and encourage SCFA production, which may support healthier responses in the liver and muscles when you’re fasting.

    In addition to fueling beneficial fermentation pathways, reducing gut dysbiosis–associated effects may help lower low-grade inflammation and protect intestinal barrier function. When the gut microbiome is less diverse or fiber intake is low, shifts in metabolites and inflammation signaling can contribute to insulin resistance. Supporting the gut barrier through a whole-food, minimally processed dietary pattern—and, for some people, including fermented foods (like yogurt with live cultures or certain fermented vegetables)—may help shift the microbial ecosystem toward more glucose-supportive activity. Over time, these changes can also influence bile acid metabolism and related metabolic pathways tied to glucose and lipid handling.

    Because individual responses vary, it helps to pair dietary strategy with clinician-guided monitoring of fasting glucose and related markers. Gradually increasing fiber, staying consistent, and observing tolerance (for example, gas/bloating) can improve adherence while giving microbes time to adapt. If carbohydrate cravings, thirst/dry mouth, or fatigue are present, they can reflect fluctuating glucose control and hydration needs—so a sustainable eating pattern that prioritizes fiber-rich, nutrient-dense carbs (rather than refined sugars) is typically the most practical way to support both the microbiome and metabolic outcomes.

  • Lifestyle recommendations

    • Increase daily fiber intake (aim for a gradual rise to ~25–38 g/day) using vegetables, legumes, whole grains, nuts, and seeds to support SCFA-producing gut bacteria.
    • Reduce intake of ultra-processed foods and added sugars, especially refined carbs, to improve fasting glucose and insulin sensitivity.
    • Include fermented foods (e.g., yogurt/kefir, sauerkraut, kimchi, kefir) if tolerated to support a more diverse, beneficial gut microbiome.
    • Adopt a consistent meal pattern with an emphasis on balanced meals (protein + fiber-rich carbs + healthy fats) to reduce glucose swings and support overnight glucose control.
    • Aim for regular physical activity (at least 150 minutes/week of moderate exercise plus some resistance training) to improve insulin sensitivity and lower fasting glucose.
    • Prioritize healthy sleep and stress management (e.g., 7–9 hours/night, mindfulness/relaxation strategies) because poor sleep and high stress can worsen insulin resistance.

  • Nutrition recommendations

    • Increase dietary fiber to support SCFA production (target a gradual goal of ~25–38 g/day): emphasize beans/lentils, chickpeas, oats, barley, chia/flax, vegetables, berries, and whole fruit rather than juice.
    • Prioritize minimally processed, high-fiber carbohydrate sources (swap refined grains and sweets for whole grains and legumes) to improve fasting glucose and insulin sensitivity overnight.
    • Include fermented foods most days if tolerated (e.g., unsweetened yogurt/kefir, kimchi, sauerkraut, tempeh) to help increase microbial diversity and beneficial metabolite production.
    • Support a gut-friendly protein and fat pattern: choose fish, poultry, tofu/tempeh, olive oil, nuts, and seeds; limit frequent high-saturated-fat and ultra-processed meals that can worsen insulin resistance.
    • Add prebiotic-rich foods to selectively feed beneficial bacteria (e.g., garlic, onions, leeks, asparagus, Jerusalem artichoke, oats, bananas that are slightly less ripe) alongside fiber staples.
    • Limit added sugars and refined carbohydrates, especially in the evening; aim for smaller portions of starch/sweets at dinner to reduce next-morning fasting glucose spikes.
    • Choose mindful hydration and timing: stay well-hydrated and avoid late-night sugary drinks; pair carbohydrates with fiber/protein/fat to blunt post-meal glucose excursions.

  • Supplement considerations

    For impaired fasting glucose (IFG), supplement choices often aim to support the gut microbiome’s ability to produce short-chain fatty acids (SCFAs) like butyrate and propionate, which are linked to improved insulin sensitivity and more stable glucose regulation—especially overnight when fasting. Approaches that provide fermentable substrate (such as prebiotic fibers) or help replenish beneficial taxa (via probiotics) may support SCFA output and help the liver and peripheral tissues respond more effectively to insulin. Because microbiome responses vary, it’s common to start gradually, choose well-studied strains when using probiotics, and select prebiotics that match your diet tolerance.

    Some supplements also target metabolic inflammation and gut-barrier integrity, which may be relevant when dysbiosis contributes to low-grade inflammatory signaling and altered intestinal permeability—factors that can worsen insulin resistance. Options that include anti-inflammatory or barrier-supporting nutrients (for example, omega-3s in some cases, and specific polyphenols derived from foods) may complement fiber- and microbiome-focused strategies. Additionally, bile acid–modulating pathways are an emerging link between the gut ecosystem and glucose handling, so interventions that influence microbial bile acid metabolism may be considered, typically alongside ongoing dietary improvements.

    Finally, supplement use for IFG is most effective when treated as an adjunct to consistent high-fiber, minimally processed nutrition, because the microbiome typically needs regular carbohydrate diversity (from plants and legumes/whole grains) to sustain SCFA production. If you’re supplementing, it can be helpful to monitor fasting glucose and other clinician-guided markers over time, adjust based on tolerance (especially for prebiotics), and be mindful of interactions or contraindications—particularly if you take glucose-lowering medications. A personalized, evidence-informed trial approach is usually better than stacking multiple products at once.

  • Retesting / monitoring note

    For impaired fasting glucose (IFG), clinicians typically recommend retesting fasting blood sugar after a focused lifestyle period—often around 8 to 12 weeks—so there’s enough time for diet, weight changes, physical activity, and gut-microbiome–supportive habits to meaningfully influence insulin sensitivity and liver glucose output overnight. If you’re implementing higher-fiber eating patterns (and, when appropriate, fermented foods), repeating the test after this window can help determine whether fasting values are improving in response to these changes. Retesting is best done under consistent conditions, such as maintaining your usual overnight fasting duration and avoiding unusual short-term changes (like intense exercise or a major diet shift) right before the blood draw.

    Depending on your initial results and overall risk profile, your clinician may also suggest pairing retesting with additional markers (for example, HbA1c, fasting insulin, or a more comprehensive metabolic panel) to clarify whether improvements are due to better glucose regulation rather than day-to-day variation. Because gut-related interventions may affect inflammation, intestinal barrier function, and metabolite production (including short-chain fatty acids that support metabolic signaling), tracking more than just one number can provide a clearer picture of progress.

    If repeat testing shows persistent IFG or worsening fasting glucose, your retesting timeline may be shortened and your plan refined, while if values normalize, periodic monitoring is still important. Many clinicians follow a trend-based approach: retest at a reasonable interval, review the trajectory alongside diet adherence and other health factors, and continue glucose-supportive changes aimed at improving microbial diversity and fiber fermentation—then reassess again to confirm sustained improvement.

The importance of gut microbiome testing

  • Why testing matters

    Gut microbiome testing can help clarify why impaired fasting glucose (IFG) may be developing even when traditional risk factors aren’t obvious. Because the gut community influences overnight glucose regulation—largely through fermentation of dietary fiber into short-chain fatty acids (SCFAs) like butyrate and propionate—your microbiome profile can provide clues about whether SCFA-producing pathways are underperforming. Identifying patterns associated with lower microbial diversity or reduced beneficial fiber-fermenters can make it easier to understand why your fasting blood sugar trends upward and which dietary levers are most likely to help.

    Testing also matters because gut dysbiosis can affect insulin sensitivity through multiple routes, including low-grade inflammation and changes in intestinal barrier function (often described as increased “gut permeability”). By revealing marker patterns linked to inflammation-associated taxa, altered microbial metabolite output, or imbalanced bile acid metabolism, microbiome results may help explain mechanisms behind insulin resistance that can worsen fasting glucose. This context is especially valuable when you’re trying to interpret persistent IFG symptoms—such as fatigue, thirst/dry mouth, frequent urination, blurred vision, or carb cravings—since the microbiome can influence metabolic signaling, energy regulation, and hunger hormones.

    Finally, microbiome testing can support a more personalized, evidence-informed approach to improving IFG. Rather than relying on generic recommendations, results can guide you toward interventions that match your gut ecosystem—such as increasing specific fiber types, adjusting carbohydrate quality, and considering fermented foods if they fit your profile—while you monitor fasting glucose and related markers with your clinician. Because individual responses vary widely, knowing your baseline microbiome can help you choose the most targeted changes and measure what’s actually working.

  • How InnerBuddies helps

    InnerBuddies can help clarify the gut–metabolism connection behind impaired fasting glucose (IFG) by providing insight into the microbial patterns that influence overnight glucose regulation. Since many beneficial gut bacteria ferment dietary fiber into short-chain fatty acids (SCFAs) such as butyrate and propionate—molecules that support healthier insulin signaling—microbiome readouts can help you understand whether your current community structure may be less optimized for SCFA production. This is especially relevant to fasting blood sugar, where the body relies heavily on efficient liver and muscle glucose handling.

    In addition to SCFA pathways, the test may highlight features associated with gut dysbiosis, including microbial profiles linked to low-grade inflammation and reduced intestinal barrier integrity (often described as “leaky gut”). These gut changes can affect insulin sensitivity through inflammation-related signaling and altered permeability, potentially contributing to IFG even in the absence of obvious traditional risk factors. By identifying imbalance patterns that may relate to these processes, InnerBuddies can help explain why some people experience IFG-related symptoms like fatigue, thirst/dry mouth, frequent urination, blurred vision, or carbohydrate cravings, which can be downstream of fluctuating glucose control and energy regulation.

    Finally, InnerBuddies supports a more personalized, evidence-informed approach to improving IFG by helping tailor diet-focused interventions to your gut ecosystem. Instead of relying on one-size-fits-all advice, the results can guide which fiber types to prioritize, whether fermented foods might be beneficial for you, and how to adjust carbohydrate quality to encourage a more glucose-supportive microbiome. When paired with clinician-guided monitoring of fasting glucose and related markers, this personalized baseline can make it easier to track what’s actually working over time.

Medical Evidence

  • Scientific evidence level

    2 [weak/emerging but inconsistent]

  • Clinical relevance note

    At present, the gut microbiome is best viewed as a biologically plausible and partly associated correlate of dysglycemia, with the strongest human signal relating to prediabetes/insulin resistance phenotypes rather than IFG alone. The literature does not yet demonstrate that microbiome measurement is sufficiently reproducible and validated to guide clinical decisions about IFG (e.g., using specific taxa/functional signatures to change management). The field also lacks consensus on robust biomarkers because of substantial methodological variation.

    Clinically actionable microbiome-based interventions specifically for IFG are not established. While some microbiome-modulating strategies may improve glycemic control in selected settings, the evidence is not strong enough to conclude a causal, reliable improvement in IFG status at the population level. Until larger, well-powered randomized trials use standardized microbiome assays, carefully controlled diets, clinically meaningful endpoints (conversion to/from IFG), and external validation of predictive features, the evidence remains hypothesis-generating to moderately supported for association, with low confidence for causality and limited clinical implementation.

    Limitations driving this low-to-moderate confidence include confounding (diet, BMI, activity, medications), reverse causality (early metabolic dysfunction influencing the microbiome), small or underpowered studies, batch effects and analytical inconsistency, stool-versus-mucosal microbiome mismatch, and predictive modeling risks (overfitting, weak cross-cohort reproducibility, lack of prospective validation).

Title Journal Year Link
The gut microbiome in prediabetes and type 2 diabetes: a metagenomic study Cell 2019 View →
Gut microbiota and insulin resistance: a systematic review and meta-analysis of observational studies BMC Gastroenterology 2017 View →
Microbiome-wide association study of fasting glucose and insulin resistance Nature Communications 2015 View →
Linking gut microbiota to insulin resistance in humans Nature Medicine 2013 View →
Gut microbiota and impaired glucose tolerance: a cross-sectional study Nature 2012 View →

Frequently Asked Questions

    Qu’est-ce que le glucose à jeun altéré (IFG) et en quoi est-il différent du diabète ?
    IFG signifie que la glycémie à jeun est plus élevée que la normale, mais pas au seuil du diabète. C’est un signe précoce de prédiabète et non un diabète. Confirmer avec un médecin et planifier les prochaines étapes.
    Comment le microbiome influence-t-il l’IFG ?
    Les microbes fermentent les fibres en SCFA (butyrate, propionate) qui peuvent améliorer la signalisation de l’insuline. La dysbiose peut favoriser l’inflammation et une barrière intestinale plus perméable, affectant la sensibilité à l’insuline.
    Quelles modifications du mode de vie aident l’IFG ?
    Alimentation riche en fibres et peu transformée; activité physique régulière; taille moyenne saine; sommeil de qualité; limiter les aliments ultra-transformés et les sucres ajoutés. La personnalisation aide.
    La consommation de fibres peut-elle améliorer l’IFG par la production de SCFA ?
    Oui. Les SCFA soutiennent la signalisation de l’insuline; les effets varient selon les personnes.
    Y a-t-il des symptômes de l’IFG à surveiller ?
    L’IFG est souvent asymptomatique. La soif, les urines fréquentes, la fatigue ou la vision floue peuvent apparaître, mais le diagnostic se fait par des prises de sang.
    Quelle est la prévalence de l’IFG et qui est à risque ?
    L’IFG est courant; on estime environ 20–30% des adultes dans de nombreuses populations. Le risque augmente avec l’âge et est lié à la graisse viscérale, faible apport en fibres, inertie et consommation élevée d’aliments ultra-transformés.
    L’analyse du microbiome aide-t-elle à gérer l’IFG ?
    Elle peut aider à comprendre les mécanismes et guider des ajustements diététiques personnalisés, mais ce n’est pas un outil diagnostic unique; interpréter avec un professionnel.
    Quels signes indiquent que l’IFG peut s’aggraver ?
    Glycémie à jeun plus élevée; soif et mictions accrues; fatigue; progression nécessite une surveillance clinique.
    L’IFG est-il réversible et peut-il prévenir le diabète ?
    Des ajustements du mode de vie peuvent améliorer le contrôle de la glycémie et réduire le risque de progression. Pas toujours réversible; surveillance régulière recommandée.
    Comment surveiller sa glycémie à jeun à domicile ?
    Utilisez un glucomètre validé et suivez les conseils du médecin; notez les valeurs et discutez des motifs préoccupants.
    Devrais-je prendre des probiotiques ou des aliments fermentés ?
    Les aliments fermentés ou les probiotiques peuvent aider certaines personnes; les preuves varient. Consultez votre médecin et privilégiez une alimentation globale équilibrée.
    Comment le sommeil, l’activité et l’alimentation influent-ils sur l’IFG ?
    Un mauvais sommeil, une faible activité et une alimentation riche en sucres raffinés aggravent l’insulinorésistance. Activité régulière, bon sommeil et alimentation riche en fibres aident.
    Y a-t-il des risques à modifier son régime sur la base de tests du microbiome ?
    Changer son régime est généralement sûr s’il est équilibré; éviter les régimes extrêmes non testés et discuter avec un médecin pour la sécurité nutritionnelle.
    Quel rôle jouent les acides biliaires dans l’IFG ?
    Le microbiome peut modifier les profils d’acides biliaires, ce qui peut influencer la régulation de la glycémie et la sensibilité à l’insuline.
    À quelle fréquence répéter le test de la glycémie à jeun ?
    Suivre les conseils du médecin; typiquement tous les 6–12 mois ou plus tôt si les facteurs de risque changent.
    Comment l’âge influence-t-il le risque d’IFG ?
    Le risque augmente généralement avec l’âge, mais l’IFG peut apparaître à tout âge selon le mode de vie.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -